What Belviq Labeling Means For Other Obesity Drug Sponsors

Arena’s Belviq is the first obesity drug approval in over a decade, but it won’t be the only one for long. A look at the FDA-approved labeling for lorcaserin offers a preview of how the agency could handle similar issues for Qnexa and, further down the line, Contrave.  

More from Archive

More from Pink Sheet